Table 1 Reprinted from Behcet’s disease ocular attack score 24: evaluation of ocular disease activity before and after initiation of infliximab by Toshikatsu Kaburaki et al.

(1) Cells in the anterior chamber (max. 4 points)

Cell 0: 0 point, cell 0.5+ or 1+ : 1 point, cell 2+ : 2 points, cell 3+ : 3 points, cell 4+ or hypopyon: 4 points

(2) Vitreous haze (max. 4 points)

Haze 0: 0 point, haze 0.5+ or 1+ : 1 point, haze 2+ : 2 points, haze 3+ : 3 points, haze 4+ : 4 points

(3) New inflammatory changes in the peripheral retina (max. 8 points)

Give each 2 points in each quadrant of peripheral retina if new inflammatory changes (exudates, hemorrhages, vasculitis) are seen

(4) New inflammatory changes in the posterior pole of retina (max. 4 points)

The percentage of areas occupying new inflammatory changes in the posterior pole of retina:

0%: 0 point, > 0 and < 10%: 2 points, ≥ 10 and < 25%: 3 points, ≥ 25%: 4 points

(5) New inflammatory changes in the fovea (max. 2 points)

Give 2 points if new inflammatory changes (exudates, hemorrhages, vasculitis) are seen in the fovea

(6) New inflammatory changes in the optic disc (max. 2 points)

Give 2 points if new inflammatory changes in the optic disc (redness and edema, sometimes accompanied by hemorrhages, exudates and edema of retina surrounding the optic disc) are seen